|
2025
|
G/S
|
Pharmaceutical agents affecting sensory organs; muscle
relaxants; preparations for the treatment... |
|
2024
|
Invention
|
Composition for stabilizing botulinum neurotoxin, botulinum neurotoxin formulation containing sam... |
|
|
Invention
|
Antibody and pharmaceutical composition comprising same for treating immune diseases. The present... |
|
2023
|
Invention
|
In-silico-designed botulinum toxin mimetic peptide for inhibiting release of neurotransmitters in... |
|
|
Invention
|
Cross-linked hyaluronic acid gel having good spreadability and stability, and use thereof. Provid... |
|
|
G/S
|
Pharmaceutical and veterinary preparations for the treatment of cerebral palsy, headaches, migrai... |
|
|
Invention
|
Botulinum toxin formulation having reduced resistance expression, and method related thereto. Pro... |
|
|
G/S
|
Analgesics; Appetite suppressants for medical purposes; Pharmaceutical preparations acting on the... |
|
|
G/S
|
Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral cant... |
|
|
Invention
|
Protein kinase inhibitor and use thereof. Provided are: a compound of chemical formula 1, having ... |
|
|
Invention
|
Lacticaseibacillus paracasei strain having periodontal pathogen inhibitory activity, and use ther... |
|
|
Invention
|
Weissella cibaria strain having dental health enhancement activity and use thereof. Provided are ... |
|
|
Invention
|
Polypeptide having hair loss treating or hair growth promoting activity and use thereof. Provided... |
|
2022
|
G/S
|
Implantable medicines for treating neurological disorders and muscle dystonia; implantable antiag... |
|
|
G/S
|
Cosmetics; non-medicated skin care preparations; skin toner; non-medicated skin serums; facial cl... |
|
|
Invention
|
Botulinum neurotoxin composition.
The present disclosure relates to a botulinum toxin compositio... |
|
|
Invention
|
Botulinum neurotoxin composition. The present disclosure relates to a Botulinum neurotoxin compos... |
|
|
Invention
|
Recombinant botulinum toxin type a light chain, recombinant botulinum toxin, and composition, use... |
|
|
Invention
|
Hyaluronic acid cross-linked product, and filler composition comprising same.
The present disclo... |
|
|
Invention
|
Hyaluronic acid cross-linked product, and filler composition comprising same. The present inventi... |
|
|
G/S
|
Pharmaceutical agents affecting sensory organs; muscle relaxants; preparations for the treatment ... |
|
|
Invention
|
Composition comprising yeast-derived extracellular vesicles as active ingredient and method. Koma... |
|
|
G/S
|
Pharmaceuticals, namely, hyaluronate acid and modified hyaluronate acid for use as a soft tissue ... |
|
2021
|
Invention
|
Anti-hvem antibody, and composition and method associated with same.
Provided are an anti-HVEM m... |
|
|
Invention
|
Anti-hvem antibody, and composition and method associated with same. Provided are an anti-HVEM mo... |
|
|
Invention
|
Anti-vegf hexameric antibody and composition comprising same.
Provided are an anti-VEGF hexameri... |
|
|
Invention
|
Anti-vegf hexameric antibody and composition comprising same. Disclosed are an anti-VEGF hexameri... |
|
|
Invention
|
Heterodimeric fc fusion protein, and composition, use, and method related to same.
Provided are ... |
|
|
Invention
|
Heterodimeric fc fusion protein, and composition, use, and method related to same. Disclosed are ... |
|
|
Invention
|
Methods for preparing bile acids.
The present disclosure provides methods of preparing cholic ac... |
|
|
Invention
|
Cancer therapeutic agent.
A cancer therapeutic agent used in combination with an immunotherapeut... |
|
|
Invention
|
Therapeutic agent for exosome-mediated disease. Disclosed is a therapeutic agent for an exosome-m... |
|
|
Invention
|
Cancer therapeutic agent. A cancer therapeutic agent used in combination with an immunotherapeuti... |
|
|
Invention
|
High-concentration anti-vegf antibody preparation and anti-vegf antibodies for use therein. Discl... |
|
|
Invention
|
Botulinum toxin pre-filled injectable formulation that facilitates discharge rate control and is ... |
|
|
Invention
|
Crosslinked hyaluronic acid and use thereof.
Provided are a cross-linked hyaluronic acid and use... |
|
|
Invention
|
Crosslinked hyaluronic acid and use thereof. Provided are a crosslinked hyaluronic acid and a use... |
|
|
Invention
|
Peptide inhibiting formation of snare complex and use thereof. Provided are a peptide inhibiting ... |
|
2020
|
Invention
|
Microorganism for improving liver function or inhibiting fat accumulation, and uses of same.
Pro... |
|
|
Invention
|
Microorganism for improving liver function or inhibiting fat accumulation, and uses of same. Prov... |
|
|
Invention
|
Extracellular vesicles derived from recombinant cells including polynucleotide encoding il-1 inhi... |
|
|
Invention
|
Methods and compositions of bile acids and salts for reduction of fat. The present invention rela... |
|
2019
|
Invention
|
Exogenous protein-expressing microorganism and use thereof. Provided are a VIP gene-expressing mi... |
|
|
Invention
|
Extracellular vesicles derived from recombinant microorganism including polynucleotide encoding t... |
|
2018
|
Invention
|
Microorganism having ability to degrade ethanol and acetaldehyde, and composition and kit each in... |
|
|
Invention
|
Promoter polynucleotide, signal polypeptide, and use thereof. Provided are a promoter polynucleot... |
|
|
Invention
|
Primer specific to non-toxic non-hemagglutinin protein gene sequence and use thereof. The present... |
|
|
Invention
|
Pluripotent stem cell culture medium and culture method using same. Provided are: a pluripotent s... |
|
|
Invention
|
Methods for preparing bile acids. The present disclosure provides methods of preparing cholic aci... |
|
2017
|
Invention
|
Method of isolating botulinum toxin from botulinum toxin-containing solution. Provided is a metho... |
|
2016
|
G/S
|
Pharmaceutical and veterinary preparations; drugs for
medical purposes; pharmaceutical drugs; me... |
|
2015
|
G/S
|
Pharmaceutical and veterinary preparations; muscle
relaxants; therapeutic drugs and agents; phar... |
|
2013
|
G/S
|
Pharmaceuticals, namely hyaluronate acid or modified
hyaluronate acid for use as a soft tissue f... |
|
2009
|
G/S
|
Botulinum toxin for the treatment of muscle spasms;
pharmaceutical preparations for the treatmen... |
